InspireMD, Inc. (NYSE: NSPR) today announced positive results from the CARENET (CARotid Embolic protection study using microNET) Trial for its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE